The cellular specificity of leptin-mediated actions in the infarcted heart

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 9-11

  Dobaczewski, Marcin ^a   Frangogiannis, Nikolaos G ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE; LEPTIN; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROLINE RICH PROTEIN; STAT PROTEIN; TAMOXIFEN;

AUTOPHOSPHORYLATION; CELL SPECIFICITY; CONFORMATIONAL TRANSITION; DISEASE EXACERBATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MESENCHYME CELL; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLE;

ANIMALS; LEPTIN; MICE; MICE, KNOCKOUT; MODELS, CARDIOVASCULAR; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 78650448848     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq354     Document Type: Editorial

References (11)

1. Holmes JW, Borg TK, Covell JW. Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng 2005;7:223-253.
2. Whelan RS, Kaplinskiy V, Kitsis RN. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 2010;72:19-44.
3. Abe Y, Ono K, Kawamura T, Wada H, Kita T, Shimatsu A et al. Leptin induces elongation of cardiac myocytes and causes eccentric left ventricular dilatation with compensation. Am J Physiol Heart Circ Physiol 2007;292:H2387-H2396.
4. McGaffin KR, Witham WG, Yester KA, Romano LC, O'Doherty RM, McTiernan CF et al. Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice. Cardiovasc Res 2011;89:60-71.
5. McGaffin KR, Sun CK, Rager JJ, Romano LC, Zou B, Mathier MA et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 2008;77:54-63.
6. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003;108:754-759.
7. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Leptin as a cardiac hypertrophic factor: a potential target for therapeutics. Trends Cardiovasc Med 2007;17:206-211.
8. Purdham DM, Rajapurohitam V, Zeidan A, Huang C, Gross GJ, Karmazyn M. A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heart. Am J Physiol Heart Circ Physiol 2008; 295: H441-H446.
9. Schram K, Wong MM, Palanivel R, No EK, Dixon IM, Sweeney G. Increased expression and cell surface localization of MT1-MMP plays a role in stimulation of MMP-2 activity by leptin in neonatal rat cardiac myofibroblasts. J Mol Cell Cardiol 2008;44:874-881.
10. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008;52: 1201-1210.
11. Zarkesh-Esfahani H, Pockley AG, Wu Z, Hellewell PG, Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004; 172:1809-1814.